Latest News

One of these chipmakers is riding a record AI-driven surge, while the other is working to reinvent itself beyond the smartphone.

These energy industry giants have long track records of dividend growth.

TELUS's attractive 6% dividend yield and ongoing business transformation could offer patient investors an opportunity to benefit from income and a potential long-term recovery.

Dutch Bros is adding drive-thru shops at a rapid clip, while Wendy's relies on a franchise model built for steady cash flow. Their valuations tell very different stories.

Fuel inflation is pressing on Bob's margins, and vendor cost-sharing is the lever management is pulling to hold profit steady.

These monthly dividend stocks stand out for their strong distribution history and ability to sustain payouts in the years ahead.

A $1,000 dividend can add $1,380 to the income used to calculate your Old Age Security recovery tax.

C.H. Robinson Worldwide (NASDAQ:CHRW) executives said the freight broker plans to continue investing in organic growth while pursuing its RXO acquisition, with Chief Financial Officer Damon Lee pointing to anticipated cost savings and reduced debt as key benefits of the deal. Speaking at a panel mo

Retiring soon? See how Scotiabank, Enbridge and XEI can generate $750 a month in dividend income to supplement your CPP payments.

WSP Global stock is down 27% this year, yet its backlog hit a record $20.3 billion. See why this TSX stock may be a long-term buy and hold pick.

Operating losses are narrowing as revenue outpaces expenses, and the company's $253 million cash pile is meant to carry it until it turns cash-flow positive.

Starship reached orbit with 26 Starlink satellites on Flight 15, but the booster was diverted into the water and burst into flames.

Booking earns a high-margin travel business with strong free cash flow, while GameStop is mid-pivot toward capital allocation. The valuation gap between them is narrower than the business models suggest.

Apple is hitting new highs, but it could go even higher.

Elevance Health (NYSE:ELV) expects adjusted earnings per share to grow at least 12% in 2027 from its recently increased 2026 baseline of at least $26.75, Chief Financial Officer Mark Kaye said at a UBS conference. Kaye said the outlook rests on improving health insurance margins, disciplined pricin

Chewy's subscription model and Shopify's merchant platform take very different paths to growth, but their valuations tell a sharper story than their business models.

The flash memory company's outlook hasn't shifted since Oct. 29. Its stock price has.

One runs thousands of stores with a sizable debt load, the other rents out millions of listings without owning a single room. Their valuation gap is wide, and the risks differ sharply.

Politics equals profits for the cable news challenger.

HLS Therapeutics (TSE:HLS) reported higher third-quarter revenue as growth in its cardiovascular portfolio offset a decline in Canadian Clozaril sales, and said it expects revenue and adjusted EBITDA growth to increase in 2027. Revenue for the three months ended Sept. 30 rose 5% year over year to $

uniQure (NASDAQ:QURE) Chief Executive Matt Kapusta said investors are focused on regulatory risk surrounding its experimental Huntington’s disease therapy, AMT-130, but may be underestimating the need for treatment and the potential commercial opportunity. Speaking at Guggenheim’s 3rd Annual Health

It wasn't a good day for tech stocks generally.

Today, Nov. 13, 2026, CoreWeave's shares slid as investors weighed a possible equipment-backed loan against its rapid buildout.

Acquisitions lift revenue sharply, but weaker residential demand forces a guidance cut.

Amgen trades at a lower forward P/E than Vertex, but Vertex's near-zero debt and cystic fibrosis dominance make the trade-off harder to call.